Recombinant human interleukin-11 (Hangzhou Jiuyuan Gene Engineering Co Ltd )

重组人白细胞介素-11（杭州九源基因工程有限公司）

Report date: 2022/04/29 17:01:18

Base Information

Drug NameRecombinant human interleukin-11 (Hangzhou Jiuyuan Gene Engineering Co Ltd )
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-11 replacements
TargetsInterleukin-11
Therapy Area/IndicationsThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHangzhou Jiuyuan Gene Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Jiuyuan Gene Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsThrombocytopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A